Related Experiment Video
Updated: Nov 30, 2025

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Large vessel thrombosis in patient with COVID-19, a case series
Aram Baram1, Fahmi H Kakamad1,2,3, Hadi M Abdullah4
1College of Medicine, University of Sulaimani, Sulaimani, Kurdistan, Iraq.
Insights
Coronavirus disease-19 (COVID-19) is a significant risk factor for large vessel thrombosis (LVT), potentially leading to severe outcomes. Vigilance and prompt surgical consultation are crucial for managing COVID-19 patients at risk of LVT.
Area of Science:
- Vascular Medicine
- Infectious Diseases
- Cardiology
Background:
- Large vessel thrombosis (LVT) is an underreported complication of Coronavirus disease-19 (COVID-19).
- Understanding the implications of LVT in COVID-19 is critical due to its potential severity.
Purpose of the Study:
- To present a case series of patients with Coronavirus disease-19 (COVID-19) and documented large vessel thrombosis (LVT).
- To highlight the association between COVID-19 and LVT.
Main Methods:
- A multicenter prospective case series involving consecutive patients diagnosed with COVID-19 and LVT.
- Large vessels were defined as those equal to or larger than the popliteal artery.
- Follow-up duration averaged 4 months.
Main Results:
- The study included 22 patients (86.4% male, mean age 48.4 years).
- Pulmonary embolism was confirmed in 18.2% of cases via CT scan.
- All patients exhibited ground glass opacities on chest CT and elevated D-Dimer levels (mean 3601 ng/ml).
Conclusions:
- Coronavirus disease-19 (COVID-19) presents a hidden risk for developing large vessel thrombosis (LVT), which can be life-threatening and necessitate major amputation.
- Even with anticoagulant therapy, COVID-19 patients remain susceptible to LVT.
- A high index of suspicion and early surgical consultation are recommended for COVID-19 patients with suspected LVT.
Introduction:
Involvement of the large vessels is rarely reported and poorly understood in cases of Corona virus disease-19 (COVID-19). The aim of this study is to present a series of cases with large vessel thrombosis (LVT).
Methods:
This is a multicenter prospective case series study. The participants were consecutive in order. All the patients were diagnosed as cases of COVID-19 with documented LVT were included in the study. Large vessels were defined as any vessel equal or larger than popliteal artery. The mean duration of follow up was 4 months.
Results:
The study included 22 cases, 19 (86.4%) cases were male, 3 (13.6%) patients were females. The age ranged from 23 to 76 with a mean of 48.4 years. Four (18.2%) cases had pulmonary embolism confirmed by IV contrast enhanced chest CT scan. All of the cases showed pulmonary parenchymal ground glass opacities (GGO) and high D-Dimers (ranging from 1267 to 6038 ng/ml with a mean of 3601 ng/ml).
Conclusion:
COVID-19 is a hidden risk factor of LVT that may endanger the patient's life and lead to major amputation. Despite therapeutic anticoagulants still all COVID-19 patients are at risk for LVT, a high index of suspicion should be created and with minimal symptoms surgical consultation should be obtained.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction
Venous Thrombosis IV: Nursing Management

